Data / Form D filings / Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc.: Form D filings
Acurx Pharmaceuticals, Inc., a pharmaceuticals company in Staten Island, NY, filed 10 Form D notices with the SEC between 2018 and 2026. The latest, on April 29, 2026, reports $4.6 million sold of a $4.6 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 259 LIBERTY AVENUE, Staten Island, NY, 10305
- Phone
- (917) 533-1469
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736243
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | New notice | $4,587,473 | $4,587,473 | 5 | Apr 15, 2026 | sec.gov | |
| Jun 27, 2025 | New notice | $3,978,664 | $3,978,664 | 1 | Jun 17, 2025 | sec.gov | |
| May 20, 2025 | New notice | $12,000,000 | $0 | $12,000,000 | 1 | May 8, 2025 | sec.gov |
| Mar 21, 2025 | New notice | $3,376,350 | $3,376,350 | 6 | Mar 10, 2025 | sec.gov | |
| Jan 17, 2025 | New notice | $2,404,259 | $2,404,259 | 12 | Jan 7, 2025 | sec.gov | |
| Jan 17, 2020 | New notice | $6,000,000 | $455,000 | $5,545,000 | 21 | Jan 6, 2020 | sec.gov |
| Oct 30, 2019 | Amendment | $7,842,500 | $7,842,500 | 202 | Mar 20, 2018 | sec.gov | |
| Oct 30, 2018 | Amendment | $7,000,000 | $3,811,500 | $3,188,500 | 72 | Mar 20, 2018 | sec.gov |
| May 31, 2018 | Amendment | $7,000,000 | $2,871,500 | $4,128,500 | 61 | Mar 20, 2018 | sec.gov |
| Apr 3, 2018 | New notice | $7,000,000 | $2,081,500 | $4,918,500 | 47 | Mar 20, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David P. Luci | Executive Officer, Director | |
| Robert J. DeLuccia | Executive Officer, Director | |
| Robert G. Shawah | Executive Officer | |
| Jack H. Dean | Director | |
| James Donohue | Director | |
| Thomas Harrison | Director | |
| Carl Sailer | Director | |
| Joseph Scodari | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Apr 27, 2026 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Acurx Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.